1.1 About the PA MPJE Exam

What the PA MPJE Is

The Pennsylvania Multistate Pharmacy Jurisprudence Examination (PA MPJE) is the state-specific pharmacy law exam that every candidate must pass before being licensed as a pharmacist in the Commonwealth of Pennsylvania. It tests knowledge of both federal pharmacy law and Pennsylvania-specific statutes and regulations, ensuring that newly licensed pharmacists can practice safely within the Commonwealth's legal framework. Passing the PA MPJE is required — together with the NAPLEX (clinical pharmacy) and 1,500 hours of supervised practical experience — under 63 P.S. § 390-5.

Who Owns the Exam

The MPJE program is owned and administered by the National Association of Boards of Pharmacy (NABP), which develops the item bank, sets the Competency Statements, and contracts with the testing vendor. The PA State Board of Pharmacy — housed within the Pennsylvania Department of State (DOS), Bureau of Professional and Occupational Affairs (BPOA) — adopts the exam as the jurisprudence requirement for PA licensure, sets the passing standard for PA candidates, and provides PA-specific items that appear alongside federal questions. The Board's authority flows from the Pharmacy Act (Act 699 of 1961), 63 P.S. §§ 390-1 et seq., and its regulations are codified in 49 Pa. Code Chapter 27. PA controlled-substance law is found separately in the Controlled Substance, Drug, Device and Cosmetic Act, 35 P.S. §§ 780-101 et seq.

Federal + State Split

There is no internal marker on the exam that tells you whether a question is testing federal or Pennsylvania law — the 120 items are blended. You must determine the applicable authority and apply the controlling rule. When federal and Pennsylvania law overlap, the stricter standard controls: if PA imposes a tighter requirement (for example, mandatory e-prescribing for CII–CV or a counseling offer for every new prescription), PA prevails; if federal law is stricter (for example, the prohibition on refilling a CII prescription), the federal rule prevails. The exam frequently tests this stricter-standard rule using scenarios where one body is silent and the other is not.

Exam Format

The PA MPJE is a fixed-length computer-adaptive test (CAT). NABP's official description states the exam is "a fixed-length computer adaptive test (CAT) delivered to match a candidate's ability level." Each answer shapes the difficulty of the next question, and the final scaled score reflects both the number of correct answers and the difficulty of those items. The exam reports only pass/fail; no diagnostic breakdown is provided except on failing score reports.

Pretest (pilot) questions are not scored and do not affect your pass/fail result; they are embedded so NABP can gather psychometric data before items count. You will not know which items are pretest, so answer every question as if it counts. The CAT format also means you cannot return to skipped questions or flag items for review.

Attempts and Retakes

NABP limits MPJE candidates to five attempts per jurisdiction. If you exhaust five attempts in Pennsylvania, you cannot retake the PA MPJE without meeting NABP's remediation requirements. After any failed attempt you must wait at least 30 days before reapplying, submit a new application through your NABP e-Profile, and pay both fees again. The $50 reschedule fee applies when you change or cancel an appointment outside the permitted window.

The March 1, 2027 Content Outline Transition

NABP has announced a new MPJE Content Outline that takes effect March 1, 2027. Until that date, the current Competency Statements — four content areas with fixed weights — continue to govern the exam. Candidates testing before March 1, 2027 should study against the current four-area blueprint (covered in Section 1.2). Candidates testing on or after March 1, 2027 should consult the updated Content Outline on NABP's website and adjust study plans accordingly. This guide is built from the current (pre-March 2027) Competency Statements; a revision is planned when the new outline goes live.

Uniform MPJE (UMPJE) Option

In 2026, NABP launched the Uniform MPJE (UMPJE) as an optional multistate jurisprudence exam that, once adopted by a state, can satisfy that state's jurisprudence requirement using a uniform federal-heavy item bank. Pennsylvania continues to administer the state-specific PA MPJE and has not substituted the UMPJE. PA candidates must take the PA MPJE; the UMPJE is mentioned here only so you are not confused if you see references to it in NABP materials.

Why the PA MPJE Matters

Passing the PA MPJE is a non-negotiable step to PA pharmacist licensure. A scaled score of 75 is the sole passing threshold; there is no partial credit. Because PA-specific rules — immunization age 8+, PDMP query triggers, opioid 7-day limits, pharmacy technician registration, child-abuse reporting — differ from neighboring states, studying PA law (not generic MPJE material) is the decisive factor in passing. Anchor your study to 49 Pa. Code Chapter 27, the Pharmacy Act (63 P.S.), and the Controlled Substance Act (35 P.S.), and to the federal CSA, 21 CFR, FDCA, and HIPAA.